Shi chun Feng

Prof. Shi chun Feng


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2024 in Cancer Science
Verified
Journal Article
Open access
TDTing Dai
Ting Dai
SQShengkui Qiu
Shengkui Qiu
XGXuesong Gao
Xuesong Gao
CZChengjin Zhao
Chengjin Zhao
ZGZhenming Ge
Zhenming Ge
SFShi chun Feng
Shi chun Feng
Gastric cancer (GC) is a highly aggressive malignancy with limited treatment options for advanced‐stage patients. Recent studies have highlighted the role of circular RNA (circRNA) as a novel regulator of cancer progression in various malignancies. However, the underlying mechanisms by which circRNA contributes to the development and progression of GC remain poorly understood. In this study, we utilized microarrays and real‐time quantitative polymerase chain reaction (qRT‐PCR) to identify and validate a downregulated circRNA, hsa_circ_0003251 (referred to as circWNK1), in paired GC and normal tissues. Through a series of in vitro and in vivo gain‐of‐function and loss‐of‐function assays, we demonstrated that circWNK1 exerts inhibitory effects on the proliferation, migration, invasion, and epithelial–mesenchymal transition (EMT) of GC cells. Additionally, we discovered that circWNK1 acts as a competitive endogenous RNA (ceRNA) for SMAD7 by sequestering miR‐21‐3p. Our findings were supported by comprehensive biological information analysis, as well as RNA pull‐down, luciferase reporter gene, and western blot assays. Notably, the downregulation of circWNK1 in GC cells resulted in reduced SMAD7 expression, subsequently activating the TGF‐β signaling pathway. Collectively, our study reveals that circWNK1 functions as a tumor suppressor in GC by regulating the miR‐21‐3p/SMAD7‐mediated TGF‐β signaling pathway. Furthermore, circWNK1 holds promise as a potential biomarker for the diagnosis and treatment of GC.

14 April 2025 in International Immunopharmacology
Verified
Journal Article
Closed access
CTChong Tang
Chong Tang
JWJing Wang
Jing Wang
MGMinglei Ge
Minglei Ge
LFLi Fu
Li Fu
JHJiayue Huang
Jiayue Huang
FWFeng Wu
Feng Wu

30 May 2025 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
WGWeiyu Guan
Weiyu Guan
XLXinran Lu
Xinran Lu
YZYin Zhang
Yin Zhang
HDHongping Ding
Hongping Ding
XLXinmei Liu
Xinmei Liu
SFShi chun Feng
Shi chun Feng
Background: The proper development of embryonic stomach in human is essential for the functionality of the adult stomach. However, the key genes, biological processes, and signaling pathways that influence stomach development in human embryogenesis are not yet fully understood.Methods: In this study, stomach samples were obtained from human embryos at developmental stages ranging from two to seven months. Through transcriptomic sequencing, we identified the differentially expressed genes and enrichment processes in the stomach at various developmental phases.Results: The results of this study indicate that genes associated with embryonic organ morphogenesis, digestive tract development, and gastric acid secretion displayed elevated expression during the early developmental stages. Additionally, a number of genes linked to cilium assembly and organization, peptide and hormone secretion and transportation, and immune response, showed increased expression during stomach maturation. Our findings elucidate that both the morphological and functional aspects of the stomach develop during the early stages of embryonic development. As gastric development, the stomach progressively acquires additional functions. This research provides insights into the intricate regulatory networks among the genes involved in embryonic digestive tract development, digestion and embryonic organ morphogenesis. Therefore, the formation of human embryonic stomach necessitates the synergistic regulation of a plethora of genes. Notably, this study not only identified traditionally recognized genes but also revealed many previously uncharacterized genes that play potential roles in stomach development and its functions.Conclusion: These findings establish a crucial basis for future studies on stomach development and the disorders arising from fetal stomach abnormalities.

27 January 2025 in International Journal of Biological Sciences
Verified
Journal Article
Open access
PDF file
SQShengkui Qiu
Shengkui Qiu
FWFeiran Wang
Feiran Wang
XGXuesong Gao
Xuesong Gao
WGWeiyu Guan
Weiyu Guan
TDTing Dai
Ting Dai
CTChong Tang
Chong Tang
Background: Recent advances in gastric cancer (GC) treatment have not substantially improved the 5-year survival rate nor have they significantly reduced the high recurrence rate. This highlights the need for further research to explore the underlying mechanisms of GC. Cell Division Cycle 5-Like Protein (CDC5L) has been implicated in various malignant behaviors of tumors.

1 February 2025 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
HZHaoyu Zhu
Haoyu Zhu
FWFei Wang
Fei Wang
XLXinran Lu
Xinran Lu
HWHao Wu
Hao Wu
CSChao Shi
Chao Shi
SFShi chun Feng
Shi chun Feng
Background: Proteinase 3 (PRTN3) has been linked to the progression of different cancer types. In this study, the expression and cell biological function of PRTN3 were investigated in gastric cancer (GC) to assess its role in GC progression. Methods: The PRTN3 levels in 20 pairs of GC tissues were detected via quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) and Western blotting, while immunohistochemical staining was used to assess the PRTN3 levels in 47 GC tissue samples. The effects of stable lentivirus-mediated PRTN3 knockdown on GC cell proliferative, cell cycle, and apoptotic activity were evaluated using Cell Counting Kit-8 (CCK-8) and colony formation assays, nude mouse models, and flow cytometry. Results: Elevated levels of PRTN3 messenger RNA (mRNA) and protein were noted in GC tissues, mostly in the cytosol. High PRTN3 levels were positively correlated with GC tumor N staging. In vitro knockdown of PRTN3 suppressed cell cycle progression, promoted apoptotic induction, and decreased the concentrations of cell cycle-associated proteins (cyclin D1, CDK4, and CDK6) and apoptosis-related Bcl-2 while inducing the upregulation of Bax. Downregulation of PRTN3 inhibited GC cell growth both in vitro and in mouse models. Conclusions: Our study found that high expression of PRTN3 is associated with GC tumor N staging. And PRTN3 silencing could regulate GC progression by inhibiting the cell cycle and promoting apoptosis in GC cells, which could be a potential target for GC diagnosis and treatment.

1 July 2026 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
XBXiang Bai
Xiang Bai
HZHaoyu Zhu
Haoyu Zhu
HLHuiwen Lin
Huiwen Lin
CSChao Shi
Chao Shi
CTChong Tang
Chong Tang
FWFei Wang
Fei Wang
Background: Protease serine 1 (PRSS1) has been implicated in various pathological processes. This study utilized bioinformatics analyses to evaluate PRSS1 expression in gastric cancer (GC) and explore its role in tumor invasion and metastasis. Methods: GC-related differentially expressed genes were identified using Gene Expression Omnibus (GEO) datasets. A combination of bioinformatics analysis and literature review identified PRSS1 as a hub gene, and its putative functions were inferred by functional enrichment analyses. PRSS1 expression levels were verified in GC tissues, cell lines, and serum samples from patients with metastatic lesions using Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR) and enzyme-linked immunosorbent assays (ELISAs), and their association with clinicopathological characteristics was analyzed. A stable PRSS1-knockdown cell line was generated to evaluate the effects of the gene on cell migration and invasion, using wound-healing and Transwell migration/invasion assays, as well as in a mouse model of peritoneal metastasis. Altered expression of epithelial-mesenchymal transition (EMT)-related and MAPK/ERK pathway proteins was examined using Western blotting and immunofluorescence. Results: PRSS1 expression was markedly upregulated in HGC-27 and MKN-45 GC cells relative to that in normal gastric mucosal cells. Serum levels of PRSS1 were significantly elevated in patients with GC, particularly those with advanced-stage disease, and were strongly correlated with unfavorable clinicopathology: vascular invasion, Tumor Node Metastasis (TNM) staging, and lymph node metastasis. Functional enrichment analyses indicated involvement of PRSS1 in multiple biological processes associated with tumor progression. Silencing of PRSS1 suppressed migration and invasion of GC cells in vitro and in vivo peritoneal dissemination. Mechanistically, PRSS1 knockdown reduced the expression of MMP2 and MMP9, increased expression of E-cadherin, reduced that of vimentin, and also modulated MAPK/ERK signaling activity. Conclusions: These findings indicate that PRSS1 is overexpressed in GC and may contribute to invasion and metastasis, possibly through induction of EMT and activation of MAPK/ERK signaling, highlighting its potential as a therapeutic target.